Production (Stage)
Medtronic plc
MDT
$89.92
$0.520.58%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 04/25/2025 | 01/24/2025 | 10/25/2024 | 07/26/2024 | 04/26/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.93B | 8.29B | 8.40B | 7.92B | 8.59B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.93B | 8.29B | 8.40B | 7.92B | 8.59B |
| Cost of Revenue | 3.15B | 2.78B | 2.94B | 2.75B | 2.96B |
| Gross Profit | 5.78B | 5.52B | 5.47B | 5.16B | 5.63B |
| SG&A Expenses | 2.70B | 2.69B | 2.73B | 2.63B | 2.53B |
| Depreciation & Amortization | 564.00M | 416.00M | 413.00M | 414.00M | 419.00M |
| Other Operating Expenses | 308.00M | -87.00M | -52.00M | 61.00M | 167.00M |
| Total Operating Expenses | 7.40B | 6.47B | 6.72B | 6.53B | 6.75B |
| Operating Income | 1.53B | 1.82B | 1.68B | 1.39B | 1.84B |
| Income Before Tax | 1.26B | 1.54B | 1.56B | 1.27B | 856.00M |
| Income Tax Expenses | 199.00M | 237.00M | 281.00M | 220.00M | 197.00M |
| Earnings from Continuing Operations | 1.06B | 1.30B | 1.28B | 1.05B | 659.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -5.00M | -9.00M | -9.00M | -6.00M | -5.00M |
| Net Income | 1.06B | 1.29B | 1.27B | 1.04B | 654.00M |
| EBIT | 1.53B | 1.82B | 1.68B | 1.39B | 1.84B |
| EBITDA | 2.22B | 2.50B | 2.36B | 2.05B | 2.49B |
| EPS Basic | 0.82 | 1.01 | 0.99 | 0.81 | 0.49 |
| Normalized Basic EPS | 0.89 | 0.82 | 0.76 | 0.66 | 0.81 |
| EPS Diluted | 0.82 | 1.01 | 0.99 | 0.80 | 0.49 |
| Normalized Diluted EPS | 0.88 | 0.82 | 0.76 | 0.66 | 0.81 |
| Average Basic Shares Outstanding | 1.28B | 1.28B | 1.28B | 1.29B | 1.32B |
| Average Diluted Shares Outstanding | 1.29B | 1.29B | 1.29B | 1.30B | 1.33B |
| Dividend Per Share | 0.70 | 0.70 | 0.70 | 0.70 | 0.69 |
| Payout Ratio | 84.94% | 69.32% | 70.63% | 86.18% | 139.60% |